Try our Advanced Search for more refined results

Drug IP Owner Says Boehringer's Overcharge Claim Is Capped

By Bonnie Eslinger (September 10, 2020, 5:00 PM BST) -- Licensing company Royalty Pharma has admitted that it overcharged Boehringer Ingelheim patent royalties for sales of its diabetes treatment, but argued in its lawsuit over unpaid money that anything it owed the German drugmaker was limited by the three-year deadline for filing a claim....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!